Use of antivirals in influenza in the elderly: Prophylaxis and therapy

Gerontology

Volumn 42, Issue 5, 1996, Pages 280-289

  Nicholson, Karl G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Amantadine; Elderly high risk influenza patients; Influenza; Influenza therapy; Prophylaxis; Rimantadine

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; RIMANTADINE;

ADULT; AGED; ANTIVIRAL ACTIVITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; GASTROINTESTINAL DISEASE; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NERVOUSNESS; NORMAL HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RESIDENTIAL CARE; REVIEW; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 0029982151     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213804     Document Type: Article

References (55)

1. Davies WL, Grunert RR, Haft RF, et al: Antiviral activity of 1-adaman-tanamine (amantadine). Science 1964;144:862-863.
2. Schwab RS, England AC, Poskanzer DC, Young RR: Amantadine in the treatment of Parkinson’s disease. JAMA 1969:208:1168-1170.
3. Zlydnikow DM, Kubar OI, Kovaleva TP, Kamforin LE: Study of rimantadine in the USSR: A review of the literature. Rev Infect Dis 1981: 3:408-421.
4. Cochran KW, Maasaab HF, Tsuno-da A, Berlin BS: Studies on the antiviral activity of amantadine hydrochloride. Ann NY Acad Sci 1965; 130:432-439.
5. Belshe RB, Burk B, Newman F, Cerruti RL, Sim IS: Resistance of influenza A virus to amantadine and rimantadine: Results of one decade of surveillance. J Infect Dis 1989; 159:430-435.
6. Tsunoda A, Maasab HF, Cochran KW, Eveland WC: Antiviral activity of alpha-methyl-l-adamantane-methylamine hydrochloride. Anti-microb Agents Chemother 1966:6: 553-560.
7. Tisdale M, Bauer DJ: The relative potencies of anti-influenza compounds. Ann NY Acad Sci 1977; 284:254-263.
8. Hayden FG, Cote KM, Douglas RG: Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents C’hemo-thcr 1989:17:865-870.
9. Schulman JL: Effect of 1-adamanta-nantinc hydrochloride (amantadine HC1) and methyl-l-adamantathyl-aminc hydrochloride (rimantadine HCI) on transmission of influenza infection in mice. Proc Soc Exp Biol Med 1968:108:1173-1178.
10. Hayden FG, Minocha A, Spyker DA, Hoffman HE: Comparativesin-gle-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrob Agents Chemother 1985:28:216-221.
11. Hayden FG, Hoffman HE, Spyker DA: Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob Agents Chemother 1983;23:458-464.
12. Tominack RL, Wills RJ, Gustavson LE, Hayden FG: Multiplc-dosc pharmacokinetics of rimantadine in elderly adults. Antimicrob Agents Chemother 1988;32:1813-1819.
13. Aoki FY, Sitar DS, Ogilvie RI: Amantadine kinetics in healthy young subjects after long-term dosing. Clin Pharmacol Thcr 1979:26: 729-736.
14. Aoki FY, Sitar DS: Amantadine kinetics in healthy elderly men: Implications for influenza prevention. Clin Pharmacol Ther 1985;37:137-144.
15. Horadanr VW, Sharp JG, Smilack JD, et al: Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med 1981: 94:454-458.
16. Capparelli EV, Stevens RC, Chow MSS, Izard M, Wills RJ: Rimantadine pharmacokinetics in healthy subjects and patients with end-stagc renal failure. Pharmacol Ther 1988: 43:536-541.
17. Wills RJ, Belshe R, Tomlinson D, et al: Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease. Clin Pharmacol Ther 1987:42:449-454.
18. Spector R: T ransport of amantadine and rimantadine through the blood-brain barrier. J Pharmacol Exp Ther 1988;244:516-519.
19. Hayden FG, Gwaltney JM, Van dc Castle RL, Adams KF, Giordani B: Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother 1981: 19:226-233.
20. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Wcb-ber-Jones J: A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982:307:580-584.
21. Millet VM, Dreibach M, Bryson YJ: Double-blind study of central nervous system side-effects of amantadine. rimantadine, and chlorpheniramine. Antimicrob Agents Chemother 1982;21:1-4.
22. Bryson YJ, Monahan C, Pollack M, Shields WD: A prospective double-blind study of side effects associated with the administration of amantadine for influenza A prophylaxis. J Infect Dis 1980:141:543-547.
23. Monto AS, Gunn RA, Bandyk MG, King CL: Prevention of Russian influenza by amantadine. JAMA 1979:241:1003-1007.
24. Brady MT, Scars SD, Pacini DL, et al: Safety and prophylactic efficacy of low-dosc rimantadine in adults during an influenza A epidemic. Antimicrob Agents Chemother 1990: 34:1633-1636.
25. Dawkins AT Jr, Gallagher LR, Togo T, Hornick RB, Harris BA: Studies on induced influenza in man. JAMA 1968:34:1095-1099.
26. Stange KC, Little DW, Blatnik B: Adverse reactions to amantadine prophylaxis of influenza in a retirement home. J Am Gcriatr Soc 1991: 39:700-705.
27. Degclau J, Somani S, Cooper SL, Irvine PW: Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home. J Am Gcriatr Soc 1990:38:428-432.
28. Arden NH, Patriarca PA, Fasano B, et al: The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A in a nursing home. Arch Intern Med 1988;148:865-868.
29. Aoki FY, Stiver HG, Sitar DS, Bou-dreault A, Ogilvie RI: Prophylactic amantadine and plasma concentra-tion-eflect relationships in healthy adults. Clin Pharmacol Ther 1985: 37:128-136.
30. Patriarca PA, Kater NA, Kendal AP, et al: Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother 1984:26:101-103.
31. Clover RD, Crawford SA, Abell TD, Ramsey CN Jr, Glezen WP, Couch RB: Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child 1986; 140:706-709.
32. Crawford SA, Clover RD, Abell TD, Ramsey CN Jr, Glezen WP, Couch RB: Rimantadine prophylaxis in children: A follow-up study. Pediatr Infect Dis J 1988:7:379-383.
33. Finklea JF, Hennessy AV, Davenport FM: A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness. Am J Epidemiol 1967:85:403-412.
34. O’Donoghue JM, Ray CG, Terry DW Jr, Beatty HN: Prevention of nosocomial influenza infection with amantadine. Am J Epidemiol 1973: 97:276-282.
35. Galbraith AE, Oxford JS, Schild GC, Watson GI: Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment. Lancet 1969:ii: 1026-1028.
36. Galbraith AW, Oxford JS, Schild GC, Watson GI: Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. Bull WHO 1969;41:677-682.
37. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989:321:1696-1702.
38. Nicholson KG, Baker DJ, Farquhar A, Hurd D. Kent J, Smith SH: Acute upper respiratory tract viral illness and influenza immunisation in homes for the elderly. Epidemiol Infect 1990;105:609-618.
39. Payler DK, Purdham PA: Influenza A prophylaxis with amantadine in a boarding school. Lancet 1984;i:502-504.
40. Atkinson WL, Arden NH, Patriarca PA, et al: Amantadine prophylaxis during an institutional outbreak of type A (H INI) influenza. Arch Intern Med 1986:146:1751-1756.
41. Mast EE, Harmon MW, Graven-stcin S, et al: Emergence and possible transmission of amantadine resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 1991; 134:988-997.
42. Degelau J, Somani SK, Cooper SL, Guay DRP, Crossley KB: Amantadine-resistant influenza A in a nursing facility. Arch Intern Med 1992; 152:390-392.
43. Houck P, Hemphill M, LaCroix S, Hirsh D, Cox N: Amantadine-resistant virus prior to drug use. Arch Intern Med 1995;155:533-537.
44. ACIP: Prevention and control of influenza. II. Antiviral agents. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43:RR-15.
45. Rabinovich S, Baldini JT, Bannister R: Treatment of influenza: The therapeutic efficacy of rimantadine HCI in a naturally occurring influenza A2 outbreak. Am J Med Sci 1969: 257:328-335.
46. Wingfield WL, Pollack D, Gruncrt RR: Therapeutic efficacy of amantadine HCI and rimantadine HCI in naturally occurring influenza A2 respiratory illness in man. N Engl J Med 1969:281:579-584.
47. Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr: Successful treatment of naturally occurring influenza A/USSR/77 HINT JAMA 1981:245:1 128-1131.
48. Hayden FG, Monto A: Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrob Agents Chemothcr 1986;29:339-341.
49. Hall CB, Dolin R, Gala CL, et al: Children with influenza A infection: Treatment with rimantadine. Pediatrics 1987:80:275-282.
50. Little JW, Hall WJ, Douglas RG, Hyde RW, Speers DM: Amantadine effect on peripheral airways abnormalities in influenza: A study in 15 studentswith natural influenza A infection. Ann Intern Med 1976:85: 177-182.
51. Little JW, Hall WJ, Douglas RG, Mudholkar GS, Speers DM, Patel K: Airways hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 1978;118:295-303.
52. Heider H, Adamczyk B, Prcsber C, Schroeder C, Fcldblum R, Indulen MK: Occurrence of amantadine and rimantadine resistant influenza A virus strains during the 1980 epidemic. Acta Virol (Praha) 1981:25: 395-400.
53. Kubar OI, Brjantscrva LE, Nikitina LE, Zlydnikov DM: The importance of virus drug resistance in the treatment of influenza with rimantadine. Antiviral Res 1989;11:313-316.
54. Hayden FG, Sperbcr SJ, Belshe RB, Clover RD, Hay AJ, Pykc S: Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Che-mother 1991:35:1741-1747.
55. Hayden FG, Hay AJ: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 1992;176:119-130.